ID	Database	Citation
2615857	Pubmed	"2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors. Klotz KN, Lohse MJ, Schwabe U, Cristalli G, Vittori S, Grifantini M. Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):679–83.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/2615857"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/2615857"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/2615857"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
3479638	Pubmed	"Enhancement of esophageal carcinogenesis induced in rats by N-amyl-N-methylnitrosamine in the presence of 12-O-tetradecanoylphorbol-13-acetate. Matsufuji H, Ueo H, Mori M, Kuwano H, Sugimachi K. J Natl Cancer Inst. 1987 Nov;79(5):1123–9.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/3479638"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/3479638"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/3479638"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
3561384	Pubmed	"Potent adenosine receptor antagonists that are selective for the A1 receptor subtype. Martinson EA, Johnson RA, Wells JN. Mol Pharmacol. 1987 Mar;31(3):247–52.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/3561384"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/3561384"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/3561384"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
3588607	Pubmed	"Adenosine receptors: development of selective agonists and antagonists. Daly JW, Jacobson KA, Ukena D. Prog Clin Biol Res. 1987;230:41–63.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/3588607"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/3588607"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/3588607"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
3703020	Pubmed	"Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue. Williams M, Braunwalder A, Erickson TJ. Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):179–83.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/3703020"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/3703020"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/3703020"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
8632302	Pubmed	"The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. Zocchi C, Ongini E, Conti A, Monopoli A, Negretti A, Baraldi PG, et al. J Pharmacol Exp Ther. 1996 Feb;276(2):398–404.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/8632302"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/8632302"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/8632302"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
12270951	Pubmed	"Molecular physiology of P2X receptors. North RA. Physiol Rev. 2002 Oct;82(4):1013–67.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/12270951"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/12270951"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/12270951"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
12919933	Pubmed	"Novel N6-substituted adenosine 5’-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury. Tracey WR, Magee WP, Oleynek JJ, Hill RJ, Smith AH, Flynn DM, et al. Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2780-7.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/12919933"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/12919933"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/12919933"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
15078215	Pubmed	"Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF). Zablocki JA, Wu L, Shryock J, Belardinelli L. Curr Top Med Chem. 2004;4(8):839–54.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/15078215"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/15078215"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/15078215"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
15261132	Pubmed	"The future of pharmacologic stress: selective A2A adenosine receptor agonists. Cerqueira MD. Am J Cardiol. 2004 Jul 22;94(2A):33D-40D; discussion 40D-42D.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/15261132"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/15261132"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/15261132"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
15279543	Pubmed	"A(1) adenosine receptor agonists: medicinal chemistry and therapeutic potential. Hutchinson SA, Scammells PJ. Curr Pharm Des. 2004;10(17):2021–39.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/15279543"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/15279543"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/15279543"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
15549298	Pubmed	"In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416. Moresco RM, Todde S, Belloli S, Simonelli P, Panzacchi A, Rigamonti M, et al. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):405–13.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/15549298"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/15549298"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/15549298"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
16141383	Pubmed	"Adenosine A2A receptors mediate GABAergic inhibition of respiration in immature rats. Mayer CA, Haxhiu MA, Martin RJ, Wilson CG. J Appl Physiol (1985). 2006 Jan;100(1):91–7.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/16141383"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/16141383"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/16141383"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
17077318	Pubmed	"ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor. Li Q, Ye K, Blad CC, den Dulk H, Brouwer J, Ijzerman AP, et al. J Pharmacol Exp Ther. 2007 Feb;320(2):637–45.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/17077318"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/17077318"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/17077318"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
18443746	Pubmed	"Recent improvements in the development of A(2B) adenosine receptor agonists. Baraldi PG, Tabrizi MA, Fruttarolo F, Romagnoli R, Preti D. Purinergic Signal. 2008 Dec;4(4):287–303.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/18443746"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/18443746"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/18443746"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
22886028	Pubmed	"Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors. Froestl W, Muhs A, Pfeifer A. J Alzheimers Dis. 2012;32(4):793–887.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/22886028"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/22886028"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/22886028"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
27078878	Pubmed	"Glutathione-Induced Calcium Shifts in Chick Retinal Glial Cells. Freitas HR, Ferraz G, Ferreira GC, Ribeiro-Resende VT, Chiarini LB, do Nascimento JLM, et al. PLoS One. 2016 Apr 14;11(4):e0153677.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/27078878"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/27078878"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/27078878"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
28229088	Pubmed	"Glutathione induces GABA release through P2X7R activation on Müller glia. Freitas HR, Reis RA de M. Neurogenesis (Austin). 2017 Feb 6;4(1):e1283188.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/28229088"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/28229088"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/28229088"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
30902655	Pubmed	"BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration. Garceau D, Chauret N. Pulm Pharmacol Ther. 2019 Jun;56:56–62.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/30902655"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/30902655"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/30902655"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
30927255	Pubmed	"Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation. Richards D, Gever JR, Ford AP, Fountain SJ. Br J Pharmacol. 2019 Jul;176(13):2279–91.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/30927255"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/30927255"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/30927255"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
31726893	Pubmed	"Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications. Marucci G, Dal Ben D, Buccioni M, Martí Navia A, Spinaci A, Volpini R, et al. Expert Opin Ther Pat. 2019 Dec;29(12):943–63.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/31726893"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/31726893"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/31726893"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
